Cellebrite DI (CLBT) News Today $22.78 -0.20 (-0.87%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Jackson Square Capital LLC Makes New Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)Jackson Square Capital LLC purchased a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 72,456 shares of the company's stock, valued at approximately $1,596,000. Several other hedgeJanuary 19 at 5:57 AM | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Short Interest UpdateCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,170,000 shares, a growth of 13.6% from the December 15th total of 1,030,000 shares. Based on an average daily volume of 1,310,000 shares, the short-interest ratio is presently 0.9 days. Currently, 1.4% of the company's stock are short sold.January 18 at 3:58 AM | marketbeat.comCellebrite DI (NASDAQ:CLBT) Reaches New 52-Week High - Time to Buy?Cellebrite DI (NASDAQ:CLBT) Hits New 12-Month High - Here's WhyJanuary 15, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 75,092 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)JPMorgan Chase & Co. raised its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 21.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 427,655 shares of the company's stock after acquiring an additional 75,092 shares during thJanuary 15, 2025 | marketbeat.comA Look At The Fair Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)January 14, 2025 | finance.yahoo.comHarbor Capital Advisors Inc. Raises Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Harbor Capital Advisors Inc. lifted its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 65.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 157,671 shares of the company's stock afterJanuary 11, 2025 | marketbeat.comCellebrite price target raised to $24 from $22 at Deutsche BankJanuary 8, 2025 | markets.businessinsider.comCellebrite Announces Participation in the 27th Annual Needham & Company Growth ConferenceJanuary 8, 2025 | markets.businessinsider.comCellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Rating of "Buy" from BrokeragesCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has earned a consensus rating of "Buy" from the eight research firms that are presently covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating. The average 1 year price target among analysts that hJanuary 7, 2025 | marketbeat.comCellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent DirectorJanuary 6, 2025 | finance.yahoo.comCellebrite DI Ltd: Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent DirectorJanuary 6, 2025 | finanznachrichten.deState Street Corp Raises Position in Cellebrite DI Ltd. (NASDAQ:CLBT)State Street Corp raised its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 7.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 443,700 shares of the company's stock after acquiring an addDecember 28, 2024 | marketbeat.comPrincipal Financial Group Inc. Buys New Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Principal Financial Group Inc. purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,389,654 shares of the company'December 26, 2024 | marketbeat.comBarclays PLC Increases Stake in Cellebrite DI Ltd. (NASDAQ:CLBT)Barclays PLC boosted its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 29.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 263,657 shares of the company's stock after acquiring an additional 59,395 shares during the period. Barclays PDecember 22, 2024 | marketbeat.comCellebrite DI - Leader in Digital ForensicsDecember 21, 2024 | msn.comCellebrite DI (NASDAQ:CLBT) Reaches New 1-Year High - What's Next?Cellebrite DI (NASDAQ:CLBT) Hits New 1-Year High - What's Next?December 20, 2024 | marketbeat.comTidal Investments LLC Buys 38,887 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)Tidal Investments LLC boosted its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 59.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 104,478 shares of the company's stock after purchasing an additDecember 18, 2024 | marketbeat.comCellebrite DI: Strategic Focus on Inseyets Platform and Complementary Applications Drive Buy Rating with Over 20% Upside PotentialDecember 17, 2024 | markets.businessinsider.comLord Abbett & CO. LLC Takes Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Lord Abbett & CO. LLC bought a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 684,220 shares of the company's stock, valued at approximately $11,523,000. Lord AbbDecember 17, 2024 | marketbeat.comCellebrite price target raised to $24 from $22 at JPMorganDecember 16, 2024 | markets.businessinsider.comSerbia used Israeli firm’s tech to enable spy campaign, Amnesty saysDecember 16, 2024 | msn.comAmnesty calls out Cellebrite DI (CLBT) for spy tech misuse in SerbiaDecember 16, 2024 | yahoo.comCellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Down 17.1% in NovemberCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 1,450,000 shares, a drop of 17.1% from the November 15th total of 1,750,000 shares. Approximately 1.7% of the company's stock are sold short. Based on an average daily trading volume, of 1,300,000 shares, the short-interest ratio is presently 1.1 days.December 16, 2024 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysJPMorgan Chase & Co. raised their target price on Cellebrite DI from $22.00 to $24.00 and gave the stock an "overweight" rating in a research report on Monday.December 16, 2024 | marketbeat.comAmnesty: Serbia used Israeli spyware to hack phones of activists, journalistsDecember 16, 2024 | msn.comPublic Employees Retirement System of Ohio Takes Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Public Employees Retirement System of Ohio acquired a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 293,115 shares of the company's sDecember 15, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Receives Consensus Rating of "Buy" from BrokeragesCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has been given an average rating of "Buy" by the eight ratings firms that are currently covering the company, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating. The average 1-year target price among brokerDecember 13, 2024 | marketbeat.comPoint72 Asset Management L.P. Purchases 39,946 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)Point72 Asset Management L.P. raised its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 68.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 98,246 shares of the company's stock after puDecember 11, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Stake Reduced by Quadrature Capital LtdQuadrature Capital Ltd trimmed its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 61.9% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 38,888 shares of the company's stock after selling 63,052 shares during the quarter. Quadrature CapitalDecember 9, 2024 | marketbeat.comTwo Sigma Advisers LP Acquires 120,000 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)Two Sigma Advisers LP increased its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 9.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,341,100 shares of the company's sDecember 8, 2024 | marketbeat.comFmr LLC Increases Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Fmr LLC grew its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 136.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 5,616,757 shares of the company's stock after purchasing an additional 3,239,307 shares during the period. Fmr LLCDecember 6, 2024 | marketbeat.comAtom Investors LP Sells 73,860 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)Atom Investors LP trimmed its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 62.0% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 45,265 shares of the company's stock after selling 73,860 shares during the quarter. Atom InDecember 4, 2024 | marketbeat.comPDT Partners LLC Makes New Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)PDT Partners LLC acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 25,303 shares of the company's stock, valued at approximDecember 4, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Takes Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 28,386 shares of the company's stock, valued at approximately $478,000. SDecember 3, 2024 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Holdings Increased by Josh Arnold Investment Consultant LLCJosh Arnold Investment Consultant LLC raised its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 99.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,850 shares of the company's sDecember 1, 2024 | marketbeat.comSummit Partners Public Asset Management LLC Takes Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Summit Partners Public Asset Management LLC purchased a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 550,737 shares of the company's stNovember 29, 2024 | marketbeat.comQuantbot Technologies LP Boosts Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Quantbot Technologies LP grew its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 77.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 114,318 shares of the company'November 29, 2024 | marketbeat.comTybourne Capital Management HK Ltd. Buys New Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Tybourne Capital Management HK Ltd. purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 115,615 shares of the company's stock, valued at approximately $1,947,November 28, 2024 | marketbeat.comCraig-Hallum Remains a Buy on Cellebrite DI (CLBT)November 26, 2024 | markets.businessinsider.comCellebrite Announces Participation in the UBS Global Technology and AI ConferenceNovember 25, 2024 | globenewswire.comTelemark Asset Management LLC Purchases Shares of 400,000 Cellebrite DI Ltd. (NASDAQ:CLBT)Telemark Asset Management LLC bought a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 400,000 shares of the company's stock, valued at approximately $6,736,000.November 22, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $19.35 Million Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Connor Clark & Lunn Investment Management Ltd. trimmed its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 6.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,148,9November 21, 2024 | marketbeat.comEmpowered Funds LLC Takes $2 Million Position in Cellebrite DI Ltd. (NASDAQ:CLBT)Empowered Funds LLC bought a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 118,890 shares of the company's stock, vNovember 21, 2024 | marketbeat.comCellebrite DI Ltd. (CLBT) Partners with Relativity to Streamline Mobile Data Collection for Legal Processes, Reducing Time from Days to HoursNovember 21, 2024 | insidermonkey.comCellebrite, Relativity deliver solutions to transform mobile data collectionNovember 20, 2024 | markets.businessinsider.comCellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection LandscapeNovember 20, 2024 | globenewswire.comCellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of "Buy" by AnalystsCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has been given a consensus rating of "Buy" by the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating. The average 1-year target price among brNovember 18, 2024 | marketbeat.comIs Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools?November 16, 2024 | msn.comPrincipal Financial Group Inc. Acquires Shares of 1,389,654 Cellebrite DI Ltd. (NASDAQ:CLBT)Principal Financial Group Inc. bought a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,389,654 shares of the company's stock,November 14, 2024 | marketbeat.comCellebrite: A Reasonable Valuation Given The Huge Cross-Sell RunwayNovember 13, 2024 | seekingalpha.com Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address CLBT Media Mentions By Week CLBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLBT News Sentiment▼0.920.49▲Average Business Services News Sentiment CLBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLBT Articles This Week▼54▲CLBT Articles Average Week Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MongoDB News Nutanix News Gen Digital News Twilio News Dynatrace News CyberArk Software News Okta News Duolingo News Bentley Systems News Nebius Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLBT) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLBT Stock Alerts